The Cigna Group
CI · Healthcare · · USDFahodi Score BUY Long-term (Investment)
66
/ 100
Technical
75
Trend & RS
87
Momentum
57
Fundamental
72
Macro
24
Liquidity
73
| Component | Score | Weight |
|---|---|---|
| Technical | 75.0 | 10% |
| Trend & RS | 87.1 | 10% |
| Momentum | 57.0 | 5% |
| Fundamental | 72.0 | 40% |
| Macro | 23.6 | 15% |
| Liquidity | 72.6 | 20% |
Trade Setup
| Entry | 296.23 |
| Stop Loss | 279.69 (5.6%) |
| Target 1 (1:1) | 312.76 (+5.6%) |
| Target 2 (2:1) | 329.31 (+11.2%) |
| ATR(14) | 8.27 (2.8%) |
| Risk per Share | 16.54 |
| Reward:Risk | 2:1 |
ATR-based levels. Adjust for support/resistance zones.
Factor Profile
| Factor | Score | Z | Bar |
|---|---|---|---|
| Value | 81.5 | +1.26 | |
| Momentum | 57.0 | +0.28 | |
| Quality | 29.3 | -0.83 | |
| Composite | 55.9 | ||
Quality Scores
Piotroski F-Score
6
/9 —
Average
✓
✓
✗
✗
✓
✗
✓
✓
✓
1. Positive Net Income
2. Positive Roa
3. Positive Cfo
4. Quality Earnings
5. Lower Leverage
6. Higher Liquidity
7. No Dilution
8. Higher Gross Margin
9. Higher Asset Turnover
Altman Z-Score
3.87
—
Safe Zone
Distress <1.81Grey 1.81–2.99>2.99 Safe
Valuation vs Peers Undervalued
| Metric | Stock | Sector | vs Peers |
|---|---|---|---|
| P/E Ratio | 13.3 | 22.0 | -40% below |
| P/B Ratio | 1.9 | 4.0 | Below |
| Dividend Yield | 2.0% | 1.5% | Above avg |
Comparing against Healthcare median multiples.
Trading at a discount to sector peers — potential value opportunity.
Intrinsic Value (DCF) Undervalued
Intrinsic Value
342.31
vs
Market Price
301.48
Upside
+13.5%
| Margin of Safety | +11.9% |
| Stage 1 PV (5yr FCF) | 22,496,433,689 |
| Terminal Value PV | 67,956,736,244 |
| Total Enterprise Value | 90,453,169,933 |
Assumptions
| Base FCF | 4,794,379,378 |
| Growth Rate (5yr) | 6.7% |
| Terminal Growth | 2.5% |
| Discount Rate (WACC) | 9.0% |
2-stage DCF: 5yr projected FCF + Gordon Growth terminal value. Estimates only — adjust growth and WACC for your own assumptions.
Position Sizing — Kelly Criterion
4.6%
Recommended Size
43.23%
Full Kelly
21.61%
Half Kelly
5.0%
Max Cap (Moderate)
Kelly inputs derived from quant score 66/100. Estimated win rate 60%, avg win 9.0%, avg loss 3.7%. Position was capped at the moderate risk maximum. This is analytical output, not a recommendation to trade.
RECOVERY
Regime: RECOVERY (40% confidence) — position size reduced 8%
Signal Summary STRONG BUY
3
Bullish Signals
1
Bearish Signals
51.82
RSI(14)
4.1972
MACD
Relative Strength (RS) IMPROVING
67
/ 99
RS Rating
O'Neil filter: <80
| RS vs SPY | ↑ RISING (+12.0% vs SPY 3M) |
| RS vs Sector | UNDERPERFORMING (Healthcare) |
| RS New High | Near 3-month high 11d since high |
| Sector Outperformance | -4.2% (3M) |
RS Line — stock / SPY (90 bars)
← older
newer →
RS vs SPY
50-day SMA of RS
IMPROVING:
Gaining momentum — the stock is starting to outperform the market. Watch for RS new high confirmation.
Technical Indicators
| Indicator | Value | Signal |
|---|---|---|
| Rsi | 51.82 | NEUTRAL |
| Macd | 4.1972 | BEARISH |
| Ma Cross | 285.68 / 280.08 | GOLDEN CROSS |
| Trend Short | ABOVE SMA50 | |
| Trend Long | ABOVE SMA200 | |
| Bollinger | MIDDLE | |
| Volume | 0.02x | LOW |
Key Levels
| Level | Price |
|---|---|
| 52-Week High | 318.05 |
| Bollinger Upper | 314.79 |
| SMA(200) | 280.08 |
| SMA(50) | 285.68 |
| SMA(20) | 298.92 |
| Current Price | 301.48 |
| Bollinger Lower | 283.04 |
| 52-Week Low | 255.53 |
| ATR(14) | 8.27 |
Advanced Technical Analysis
Click to expand
Wyckoff Phase & Volume Spread Analysis
Wyckoff Phase
Insufficient data for Wyckoff analysis.
Volume Spread Analysis (last 5 bars)
| Date | Signal | Vol | Description |
|---|---|---|---|
| 2026-11-02 | Normal | 0.98x | Normal bar — no special VSA pattern |
| 2026-11-03 | Normal | 1.21x | Normal bar — no special VSA pattern |
| 2026-11-04 | Normal | 1.58x | Normal bar — no special VSA pattern |
| 2026-11-05 | Normal | 1.8x | Normal bar — no special VSA pattern |
| 2026-11-06 | No Supply | 0.02x | Low volume, narrow spread, firm close — no selling pressure |
Ichimoku Cloud NEUTRAL
| Line | Value | Status |
|---|---|---|
| Tenkan-sen (9) | 304.99 | Above Kijun |
| Kijun-sen (26) | 292.02 | Base line |
| Senkou A | 298.51 | Leading span A |
| Senkou B | 290.45 | Leading span B |
| Cloud | 290.45 – 298.51 | Bullish (Green) |
| Price vs Cloud | 296.23 | Inside Cloud |
| Chikou Span | 270.53 | Bullish |
| Alignment Score | 3/4 | NEUTRAL |
TTM Squeeze & Divergences
TTM Squeeze
SQUEEZE OFF
No squeeze
Momentum:
BEARISH
BB: 283.04 – 314.79 | KC: 286.67 – 311.16
Divergences (last 60 bars)
No significant divergences detected in the last 60 bars.
Anchored VWAP
VWAP: 276.95
Anchor: 2025-11-07 (52w Low)
ABOVE AVWAP
+7.0%
Heikin-Ashi Trend
WEAKLY BEARISH
Full data via /api/advanced/CI
Valuation
| Metric | Value |
|---|---|
| Market Cap | 79.66B |
| P/E (TTM) | 13.29 |
| Forward P/E | N/A |
| P/B | 1.90 |
| EPS | 22.68 |
Financial Health
| Metric | Value |
|---|---|
| Revenue Growth | 6.7% |
| Profit Margin | 2.3% |
| ROE | 16.8% |
| Debt/Equity | 74.29 |
| Current Ratio | 0.85 |
| Dividend Yield | 2.0% |
| Payout Ratio | N/A |
| Beta | 0.25 |
Trading Data
301.48
Open
301.48
Day High
301.48
Day Low
2.77M
Volume (1.8x avg)
Price Chart (90 Days)
Candlesticks (green=up, red=down)
SMA 20
SMA 50
Bollinger Bands (upper/lower)
Volume (green=buying, red=selling)